|
End-of-day quote
Shenzhen S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 9.910 CNY | +1.95% |
|
+1.95% | -8.66% |
| Market Cap | 5.06B 756M 674M 628M 571M 1.08B 73.17B 1.09B 7.54B 2.95B 37.21B 2.84B 2.78B 119B | P/E 2024 |
224x | P/E 2025 | 67.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.99B 745M 664M 619M 563M 1.06B 72.12B 1.07B 7.44B 2.91B 36.68B 2.8B 2.74B 118B | EV / Sales 2024 |
6.57x | EV / Sales 2025 | 5.78x |
| Free-Float |
59.54% | Yield 2024 |
0.56% | Yield 2025 | 1.38% |
| 1 day | +1.95% | ||
| 1 week | +1.95% | ||
| 1 month | +10.48% | ||
| 3 months | +3.99% | ||
| 6 months | -9.91% | ||
| Current year | -8.66% |
| 1 month | 8.96 |  | 10.15 |
| Current year | 7.66 | | 14.47 |
| 1 year | 7.66 | | 15.21 |
| 3 years | 6.79 | | 17.49 |
| 5 years | 5.64 | | 19.64 |
| 10 years | 5.01 | | 20.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rong Huang Xu
CEO | Chief Executive Officer | 34 | 2025-07-15 |
Xi Liang Chen
DFI | Director of Finance/CFO | 54 | 2009-06-14 |
Ru Qing Yao
PRN | Corporate Officer/Principal | 43 | 2020-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Xi Liang Chen
BRD | Director/Board Member | 54 | 2009-06-14 |
Bei Jing Lu
BRD | Director/Board Member | 43 | 2022-06-26 |
Rong Huang Xu
CHM | Chairman | 34 | 2025-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/7/24 | Buy | Chief Financial Officer | 42,000 | 0.0188% | ||
| 6/14/23 | Buy | Chief Financial Officer | 42,000 | 0.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.95% | +1.95% | +15.10% | -10.20% | 755M | |
| +2.70% | +0.35% | +40.67% | +110.31% | 1,032B | |
| +1.44% | -3.41% | +37.36% | +63.95% | 614B | |
| +1.75% | +3.07% | +17.89% | +83.05% | 471B | |
| +0.60% | -4.35% | +60.80% | +37.46% | 350B | |
| +2.92% | +3.06% | +24.83% | +45.10% | 337B | |
| +2.42% | -0.74% | +13.44% | +35.80% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.60% | -2.49% | +40.45% | +54.44% | 218B | |
| +1.82% | -2.93% | +29.29% | +96.48% | 179B | |
| Average | +1.33% | -2.98% | +27.51% | +52.86% | 371.56B | |
| Weighted average by Cap. | +0.71% | -3.18% | +32.16% | +70.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 688M 103M 91.56M 85.4M 77.6M 146M 9.94B 148M 1.03B 401M 5.06B 386M 377M 16.24B | 925M 138M 123M 115M 104M 196M 13.37B 198M 1.38B 539M 6.8B 519M 507M 21.82B |
| Net income | 20.5M 3.06M 2.73M 2.54M 2.31M 4.36M 296M 4.4M 30.55M 11.94M 151M 11.5M 11.25M 484M | 81.67M 12.2M 10.87M 10.14M 9.21M 17.36M 1.18B 17.53M 122M 47.59M 600M 45.81M 44.81M 1.93B |
| Net Debt | 58.68M 8.77M 7.81M 7.29M 6.62M 12.47M 848M 12.59M 87.47M 34.19M 431M 32.91M 32.2M 1.39B | -72.61M -10.85M -9.67M -9.02M -8.19M -15.43M -1.05B -15.58M -108M -42.31M -534M -40.73M -39.84M -1.71B |
Employees
1,434
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥9.910 | +1.95% | 19,431,596 |
| 26-09-29 | CN¥9.720 | +0.52% | 15,743,319 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002728 Stock
Select your edition
All financial news and data tailored to specific country editions
